Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients. - Razia, Deepika; Chengcheng Hu; Cherrier, Lauren; Nasar, Aasya; Walia, Rajat; Tokman, Sofya (Transplant Immunology, 2022)